Background: Many statistical analyses, clinical trials and cost-utility analyses designed to measure the impact of a particular disease on utility scores often overlook the important influence of co-morbidity burden.
Objectives: This study aims to examine the impact of co-morbidity burden on EQ-5D index scores in a nationally representative sample of the US.
Methods: The pooled 2001 and 2003 Medical Expenditure Panel Survey was used. The total number of chronic conditions for each individual was calculated based on Clinical Classification Categories codes. Spline regression was used to identify nonlinear age effects: individuals were separated into four quartiles based on age. Censored least absolute deviation was used to regress EQ-5D index scores on age and chronic co-morbidity, controlling for income, gender, race, ethnicity, education, physical activity and smoking status. Interactions between age and chronic conditions were also explored.
Results: The coefficients for chronic co-morbidities were highly statistically significant with large magnitudes for those with two or more chronic conditions (coefficient two chronic conditions=-0.16; coefficient nine chronic conditions=-0.28). After controlling for chronic co-morbidities and other confounders, age was not statistically significant except for those aged >58 years and the magnitude of this coefficient was very small (coefficient aged >58 years=-0.0006). The interactions between age and chronic comorbidity were significant, but the deleterious impact of their interaction was largely dominated by the existence and number of chronic conditions.
Conclusions: Chronic conditions have a significant deleterious impact on EQ-5D index scores that is much more pronounced than age and other sociodemographic and behavioural characteristics. Future analyses and costutility models should incorporate the impact of multiple morbidity.
Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996Google Scholar
Drummond MF. Methods for the economic evaluation of health care programmes. 2nd rev. ed. Oxford: Oxford University Press, 1997Google Scholar
van den Akker M, Buntinx F, Roos S, et al. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol 2001; 54: 675–9PubMedCrossRefGoogle Scholar
Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269–76PubMedCrossRefGoogle Scholar
Fortin M, Bravo G, Hudon C, et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005; 3: 223–8PubMedCrossRefGoogle Scholar
Kahn LS, Fox CH, Olawaiye A, et al. Facilitating quality improvement in physician management of comorbid chronic disease in an urban minority practice. J Natl Med Assoc 2007; 99: 377–83PubMedGoogle Scholar
Fortin M, Bravo G, Hudon C, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 2006; 15: 83–91PubMedCrossRefGoogle Scholar
Gijsen R, Hoeymans N, Schellevis FG, et al. Causes and consequences of comorbidity: a review. J Clin Epidemiol 2001; 54: 661–74PubMedCrossRefGoogle Scholar
Bayliss EA, Bayliss MS, Ware Jr JE, et al. Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem list. Health Qual Life Outcomes 2004; 2: 47PubMedCrossRefGoogle Scholar
Noel PH, Williams Jr JW, Unutzer J, et al. Depression and comorbid illness in elderly primary care patients: impact on multiple domains of health status and well-being. Ann Fam Med 2004; 2: 555–62PubMedCrossRefGoogle Scholar
Shaw JW, Johnson JA, Coons SJ. U.S. valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005; 43 (3): 203–20PubMedCrossRefGoogle Scholar
Stata [computer program]. Version 9.2. College Station (TX): StataCorp, 2006Google Scholar
Sullivan PW, Ghushchyan V. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making 2006; 26: 401–9PubMedCrossRefGoogle Scholar
Lubetkin EI, Jia H, Franks P, et al. Relationship among sociodemographic factors, clinical conditions, and healthrelated quality of life: examining the EQ-5D in the U.S. general population. Qual Life Res 2005; 14: 2187–96PubMedCrossRefGoogle Scholar
Ko Y, Coons SJ. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin 2006; 22: 2065–71PubMedCrossRefGoogle Scholar
Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Curr Med Res Opin 2006; 22: 2439–48PubMedCrossRefGoogle Scholar
Basu A, Dale W, Elstein A, et al. A linear index for predicting joint health-states utilities from single health-states utilities. Health Econ 2009; 18: 403–19PubMedCrossRefGoogle Scholar
Hanmer J, Vanness D, Gangnon R, et al. Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions. J Clin Epidemiol 2010; 63 (3): 331–41PubMedCrossRefGoogle Scholar
Bo H, Fu AZ. Predicting utility for joint health states: a general framework and a new nonparametric estimator. Med Decis Making 2010; 30 (5): E29–39CrossRefGoogle Scholar
Schneeweiss S, Wang PS, Avorn J, et al. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med 2004; 19: 444–50PubMedCrossRefGoogle Scholar
Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854–64PubMedCrossRefGoogle Scholar
Byles JE, D’Este C, Parkinson L, et al. Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol 2005; 58: 997–1005PubMedCrossRefGoogle Scholar
Crabtree HL, Gray CS, Hildreth AJ, et al. The comorbidity symptomscale: a combined disease inventory and assessment of symptom severity. J Am Geriatr Soc 2000; 48: 1674–8PubMedGoogle Scholar
Fan VS, Au D, Heagerty P, et al. Validation of case-mix measures derived from self-reports of diagnoses and health. J Clin Epidemiol 2002; 55: 371–80PubMedCrossRefGoogle Scholar
Hallstrom AP, Cobb LA, Yu BH. Influence of comorbidity on the outcome of patients treated for out-of-hospital ventricular fibrillation. Circulation 1996; 93: 2019–22PubMedCrossRefGoogle Scholar
Robinson JR, Young TK, Roos LL, et al. Estimating the burden of disease: comparing administrative data and self-reports. Med Care 1997; 35: 932–47PubMedCrossRefGoogle Scholar
Silliman RA, Lash TL. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med Care 1999; 37: 339–49PubMedCrossRefGoogle Scholar
Berkanovic E, Telesky C. Mexican-American, black-American and white-American differences in reporting illnesses, disability and physician visits for illnesses. Soc Sci Med 1985; 20: 567–77PubMedCrossRefGoogle Scholar
Stewart AL, Napoles-Springer A. Health-related quality-oflife assessments in diverse population groups in the United States. Med Care 2000; 38 (9 Suppl.): II 102–24Google Scholar
Johnson TP, O’Rourke D, Chavez N, et al. Cultural variations in the interpretation of health survey questions. In: Warnecke RB, editor. Health survey research methods. Hyattsville (MD): National Center for Health Statistics, 1996: 57–62Google Scholar